???global.info.a_carregar???
Maria Emilia Carreira Saraiva Monteiro is a Medical Doctor (Universidad de Navarra, Spain) and full professor of Pharmacology at Nova Medical School, Universidade Nova de Lisboa since 2012. Has a PhD in Biomedical Sciences (1994) by Universidade do Porto (Portugal) and a PhD in Physiology by Universidad de Navarra. She is senior investigator at CEDOC-iNOVA4Health, integrated in the group Cardiovascular, Renal and Metabolic Pharmacology, lead by Sofia Pereira. She coordinated the iNOVA4Health thematic line Cardio Metabolic Disorders and member of the executive committee of INOVA4Health research unit (graded with Excellent by the Portuguese funding agency) (2020-2024). Her main scientific interests are Pharmacology of Cardiovascular and metabolic diseases related with oxygen disturbances (eg. sleep apnea). She has experience in both animal models and clinical studies with analytical approaches. More recently she has been particularly dedicated to develop infrastructures to implement investigator initiated clinical trials. Supervised 11 PhD thesis already finished (7 PhD-FCT grants and 4 medical doctors) and published 92 scientific articles that generated 1832 citations (Scopus h-index 24). Is the chair of the curricular unit in graduate programes (Core methodologies in biomedical and clinical research - PhD program in Health Sciences, NOVA Medical School) and involved in several graduate programes in the area of clinical research and pharmaceutical medicine. Presently, is member of the ERA4Health Partnership: Fostering a European Research Area for Health Research. Coordinator of Pillar 2B.1 – Investigator Initiated Clinical Studies (IICS); the Portuguese delegate at the Strategic Working Group on Health and Food of the European Strategy Forum on Research Infrastructures (ESFRI), president of the general assembly of PtCRIN (Portuguese Clinical Research Infrastructure network), is senior clinical and scientific lead of the academic clinical trial unit NOVACRU; is member of the Collaborative-CoLab Trials (a public-private association supported by european infrastructure funds to foster innovation); Coordinator/expert of higher education evaluation panels for the Agency for Assessment and Accreditation of Higher Education - A3ES in the area of health and Vice-President of the Portuguese Academy of Medicine. Was the founder and chief of the consortium PtCRIN, integrated in the national and European roadmap of research infrastructures (2014-2024); was member (evaluation of clinical trials) of the National Ethics Committee for Clinical Research (CEIC) (2009-2024); was member of the scientific council of the ANSM, Agence Nationale de Sécurité du Medicament et des Produits de Santé (France) (2013-2023). Was coordinator of the PhD grant evaluation in the area of Clinical Medicine and Health Sciences of Fundação para a Ciência e Tecnologia (2021 and 2022). Was vice-dean for education of Nova Medical School from 2010-2017 and Delegate of Portugal in the FP 7 and Horizon 2020- topic, SC1 "Health, demographic change and wellbeing". Has been involved in the evaluation of research infrastructures in the Czech Republic; member of the Comité Científico Asesor Externo de SCReN¿, (Spanish Clinical Research network); co-director of the Portugal Clinical Scholars Research Training (PTCSRT) from Harvard Medical School (2012-2022); President of the International Society for Arterial Chemoreception (ISAC) and of the Portuguese Society of Pharmacology.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Maria Emília Carreira Saraiva Monteiro

Nomes de citação

  • Monteiro, EC

Identificadores de autor

Ciência ID
5918-54A6-FAA0
ORCID iD
0000-0002-0570-0765

Telefones

Telemóvel
  • (351) 965519075 (Pessoal)

Moradas

  • Campo Mártires da Pátria, 130, 1150-090, Lisbon, Lisbon, Portugal (Profissional)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Básica - Farmacologia e Farmácia
  • Ciências Médicas e da Saúde - Ciências da Saúde
  • Ciências Médicas e da Saúde - Medicina Clínica
  • Ciências Médicas e da Saúde - Medicina Clínica

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português (Idioma materno)
Inglês Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2)
Espanhol; Castelhano Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2)
Formação
Grau Classificação
2008
Concluído
 Habilitation (Outros)
Universidade Nova de Lisboa, Portugal
1994
Concluído
 PhD in Medicine (Doutoramento)
Especialização em Pharmacology
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"Efeitos Respiratórios e Cardiovasculares da Adenosina in Vivo" (TESE/DISSERTAÇÃO)
1984
Concluído
 PhD in Medicine (Doutoramento)
Especialização em Physiology
Universidad de Navarra Facultad de Medicina, Espanha
1982
Concluído
 Medicine (Licenciatura)
Universidad de Navarra Facultad de Medicina, Espanha
Percurso profissional

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2012 - Atual Professor Catedrático (Docente Universitário) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal

Cargos e Funções

Categoria Profissional
Instituição de acolhimento 		Empregador
2022 - Atual ESFRI Delegate in the Strategic Working Group Health and Food Fundação para a Ciência e a Tecnologia, Portugal
ESFRI - European Strategic Forum For Research Infrastructures, Bélgica
2019 - Atual Chair of the Curricular Unit Core Methodologies in Biomedical and Clinical Research, PhD Program in Health Sciences Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2013 - Atual Senior Clinical and Scientific lead of the academic clinical trial unit NOVACRU Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2021 - 2024 Council Member, Portuguese Academy of Medicine representative Federation of European Academies of Medicine, FEAM, Bélgica
Federation of European Academies of Medicine, FEAM, Bélgica
2020 - 2024 Coordinator of the National Roadmap Infrastructure PtCRIN, Portuguese Clinical Research Infrastructure Network, Portugal
PtCRIN, Portuguese Clinical Research Infrastructure Network, Portugal
(...)
2018 - 2024 Coordinator of the Thematic Line "Cardio Metabolic Disorders" of the Portuguese Research Unit iNOVA4health Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
iNOVA4Health, Portugal
2018 - 2024 iNOVA4Health Management Board Universidade Nova de Lisboa, Portugal
iNOVA4Health, Portugal
2014 - 2024 Member of the Network Committee European Clinical Research Infrastructure Network, França
European Clinical Research Infrastructure Network, França
2012 - 2024 Coordinator of the Portuguese Cinical Research Infraestructures Network (PtCRIN), the national partner of the ECRIN/ERIC Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2009 - 2024 Member CEIC, Comissão de Ética para a Investigação Clínica, Portugal
CEIC, Comissão de Ética para a Investigação Clínica, Portugal
2013 - 2023 Member of the Scientific Council Agence nationale de sécurité du médicament et des produits de santé, França
Agence nationale de sécurité du médicament et des produits de santé, França
2021 - 2022 Coordinator of the PhD grant panel, Clinical Medicine and Health Sciences Fundação para a Ciência e a Tecnologia, Portugal
Fundação para a Ciência e a Tecnologia, Portugal
2019 - 2022 Chair of the Curricular Unit Pathophysiology and Therapeutic Targets, Integrated Master in Medicine Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2015 - 2022 Co-Director, Portugal Clinical Scholars Research Training (PTCSRT) Harvard Medical School, Estados Unidos
Harvard Medical School, Estados Unidos
2008 - 2022 Principal Investigator of the research group of Translational Pharmacology Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
(...)
2017 - 2020 Chair of the Curricular Unit Medical Devices, Integrated Master in Medicine Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2003 - 2018 Chair of the Curricular Units Pharmacology and/or General Pharmacology, Integrated Master of Medicine Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2010 - 2017 Subdirector de Unidade Orgânica Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2020 - 2023 CEDOC (Chronic Diseases Center)_Member of the executive board Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal
Projetos

Bolsa

Designação Financiadores
2022/01/01 - 2028/12/31 ERA4Health Partnership: Fostering a European Research Area for Health Research. Co-funded by the European Union under the Horizon Europe Framework Programme. Grant Agreement Nº: 101095426
Grant Agreement Nº: 101095426
Investigador
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Em curso
2021/11/01 - 2024/10/31 Conscious II, Curriculum development of Human Clinical Trials
2021-1-CZ01-KA220-HED-000023177
Investigador
Universidade Nova de Lisboa, Portugal
 European Commission
Em curso
2020 - 2022 Relevance of the Ratio Kynurenine/Tryptophan to Characterize Hypertension Associated to Obstructive Sleep Apnea (KYNTOSA)
PTDC/MED-TOX30418/2017
Investigador responsável
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Em curso
2019 - 2021 CONSCIOUS, Curriculum Development of Human Clinical Trials for the Next Generation Biomedical Students
2018-1-HU01-KA203-047811
Investigador
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
 European Commission
Concluído
2015/04/18 - 2015/09/17 HivKIomics - new insights on tubular injury and nephrotoxicity diagnosis and prediction in HIV-infected patients
info:eu-repo/grantAgreement/FCT/3599-PPCDT/134817/PT
Universidade Nova de Lisboa Medical School, Portugal
 Fundação para a Ciência e a Tecnologia
Concluído
2011/03/01 - 2013/12/31 Is insulin a stimulus for carotid body activation? A new mechanism for insulin resistance and hypertension.
PTDC/SAU-ORG/111417/2009
grant.Provided by PTCRIS: 111417
Universidad de Valladolid, Espanha

Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal

Universidade Nova de Lisboa Medical School, Portugal

Centro Hospitalar Universitário de Lisboa Central EPE, Portugal
The Foundation for Science and Technology

Fundação para a Ciência e a Tecnologia
Concluído

Projeto

Designação Financiadores
2023/09/01 - Atual Life Sciences for a Healthy and Sustainable Future
LA/P/0087/2020
10.54499/LA/P/0087/2020
Universidade Nova de Lisboa Molecular Structural and Cellular Microbiology, Portugal

Universidade Nova de Lisboa, Portugal

GREEN-IT, Portugal

Instituto de Biologia Experimental e Tecnológica, Portugal

Instituto Gulbenkian de Ciência, Portugal

Universidade de Lisboa Centro de Estudos Comparatistas, Portugal

Universidade de Trás-os-Montes e Alto Douro Centro de Investigação e de Tecnologias Agro-Ambientais e Biologicas, Portugal

Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2020 - Atual Muscle up with intermittent hypoxia: a matter of intensity, gender and metabolism
iNOVA4Health- IUDB/004462/2020/TL2/P2
Investigador
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal

Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal

iNOVA4Health, Portugal
iNOVA4Health

Fundação para a Ciência e a Tecnologia
Em curso
2018 - Atual AhR-CYP1A: linking environmental exposure and sleep apnea to improve arterial hypertension management
PTDC/MED-TOX/30418/2017
Investigador responsável
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
 Fundação para a Ciência e a Tecnologia
Em curso
2017 - Atual Efficacy of olive oil and phenolic compounds in reversing hypertension induced by chronic intermittent hypoxia
FCT20160102021
iNOVA4Health – MULTI/04462
iNOVA4Health MULTI/04462
Investigador
iNOVA4Health, Portugal
 Fundação para a Ciência e a Tecnologia

iNOVA4Health
Em curso
2014 - 2024 Portuguese Clinical Research Infrastructures network (PtCRIN)
2013/713/EU
Investigador responsável
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
 Fundação para a Ciência e a Tecnologia
Em curso
2014 - 2024 Portuguese Clinical Research Infrastructures network (PtCRIN)
2013/713/EU
 Fundação para a Ciência e a Tecnologia
2019 - 2021 Variability of 1A1 sulfotransferase activity in humans: an approach to predict drug response - 2nd part: Analysis of inter-individual variability in hypertensive patients.
EudraCT 2019-002266-12 and CEIC 20191098
Orientador
Hospital da Luz Lisboa, Portugal
Em curso
2016 - 2019 Variability of sulfotransferase 1A1 activity in humans: an approach to improve predictive drug response? Part I: Analysis of intraindividual variation in healthy adults
Protocol nº HLUZ_001_2016; EudraCT nº: 2016-001395-29
Investigador responsável
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
 Hospital da Luz Lisboa
Concluído
2011 - 2014 Hepatic toxicity in HIVinfected individuals exposed to nevirapine
PTDC/SAUORG/ 111663/2009
Investigador responsável
Fundação para a Ciência e a Tecnologia
2011 - 2014 Chronic Intermitent Eucapnic Hypoxia: systemic effects and evaluation of antihypertensive drugs efficacy
PTDC/SAUTOX/112264/2009
Investigador responsável
Fundação para a Ciência e a Tecnologia
Concluído
Produções

Publicações

Artigo em conferência
  1. Gracio, Patricia C.; Goncalves-Dias, Clara; Lopes-Coelho, Filipa; Monteiro, Emilia C.; Serpa, Jacinta; da Silva, Claudia L.; Pereira, Sofia A.. "Changes in N-acetyltransferase 8 in kidney tubular cell: injury, recovery and mesenchymal stromal cell-based therapy". 2019.
    10.1109/enbeng.2019.8692517
  2. Diogo, Lucilia N.; Pereira, Sofia A.; Nunes, Ana R.; Afonso, Ricardo A.; Santos, Ana I.; Monteiro, Emilia C.. "Hypertension induced by chronic intermittent hypoxia: Effects of carvedilol in a rat model". 2015.
    10.1183/13993003.congress-2015.oa294
Artigo em revista
  1. Antonio B. Pimpao; Teixeira-Santos, Luísa; Coelho, Nuno R.; Correia, Maria João; Morello, Judit; Alexandra M. M. Antunes; Monteiro, EC; Sofia Azeredo Pereira. Autor correspondente: Sofia Azeredo Pereira. "Biotransformation of Ketamine in terminal in vivo experiments under Chronic Intermittent Hypoxia conditions and the role of AhR". Archives of Toxicology Ms. No. ATOX-D-25-00044R1 (2025):
    Aceite para publicação
  2. Rychlícková, Jitka; Cechová, Zora; Nagy, Viktoria; Nebeská, Katerina; Soucková, Lenka; Mouly, Stéphane; Kovacs, Gabor Laszlo; et al. "Enhancing pragmatic competence in investigator-initiated clinical trials: structure and evaluation of the CONSCIOUS II training programme". BMC Medical Education 25 1 (2025): https://doi.org/10.1186/s12909-025-07054-5.
    10.1186/s12909-025-07054-5
  3. Claire Arnaud; Emma Billoir; Antonio F. de Melo Junior; Sofia A. Pereira; Ken D. O'Halloran; Emilia C. Monteiro. "Chronic intermittent hypoxia-induced cardiovascular and renal dysfunction: from adaptation to maladaptation". The Journal of Physiology (2023): https://doi.org/10.1113/JP284166.
    10.1113/JP284166
  4. Baltazar, Pedro; de Melo Junior, Antonio Ferreira; Fonseca, Nuno Moreira; Lança, Miguel Brito; Faria, Ana; Sequeira, Catarina O.; Teixeira-Santos, Luísa; et al. "Oxalate (dys)Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity". Genes 14 9 (2023): 1719. https://doi.org/10.3390/genes14091719.
    10.3390/genes14091719
  5. Pimpão, António; Sousa, Cátia; Correia, M João; Coelho, Nuno; Monteiro, EC; Melo Junior, AF; Pereira, Sofia A.. "Control of Arterial Hypertension by the AhR Blocker CH-223191: A Chronopharmacological Study in Chronic Intermittent Hypoxia Conditions". Advances in Experimental Medicine and Biology 147 (2023):
    Publicado • https://doi.org/10.1007/978-3-031-32371-3_4
  6. Conde, Sílvia V.; Martins, Fátima O.; Dias, Sara S.; Pinto, Paula; Bárbara, Cristina; Monteiro, Emília C.. "Dysmetabolism and Sleep Fragmentation in Obstructive Sleep Apnea Patients Run Independently of High Caffeine Consumption". Nutrients 14 7 (2022): 1382. https://doi.org/10.3390/nu14071382.
    10.3390/nu14071382
  7. Correia, Maria João; Pimpão, António B.; Fernandes, Dalila G. F.; Morello, Judit; Sequeira, Catarina O.; Calado, Joaquim; Antunes, Alexandra M. M.; et al. "Cysteine as a Multifaceted Player in Kidney, the Cysteine-Related Thiolome and Its Implications for Precision Medicine". Molecules 27 4 (2022): 1416. http://dx.doi.org/10.3390/molecules27041416.
    Publicado • 10.3390/molecules27041416
  8. Coelho, N. R.; Pimpão, A. B.; Correia, M. J.; Rodrigues, T. C.; Monteiro, E. C.; Morello, J.; Pereira, S. A.. "Pharmacological blockage of the AHR-CYP1A1 axis: a call for in vivo evidence". Journal of Molecular Medicine 100 2 (2021): 215-243. http://dx.doi.org/10.1007/s00109-021-02163-2.
    Publicado • 10.1007/s00109-021-02163-2
  9. Pinheiro Andrade, Maria; Matias, Daniela; Batuca, Joana; Gouveia, Nélia; Mota-Filipe, Hélder; Carreira Monteiro, Emília; Madeira, Catarina. "Portuguese Authorship in Published Clinical Trials: Differences in Industry and Investigator Initiated Trials". Acta Médica Portuguesa 34 11 (2021): 733. http://dx.doi.org/10.20344/amp.14554.
    Publicado • 10.20344/amp.14554
  10. Correia, Maria João; Pimpão, António B.; Lopes-Coelho, Filipa; Sequeira, Catarina O.; Coelho, Nuno R.; Gonçalves-Dias, Clara; Barouki, Robert; et al. "Aryl Hydrocarbon Receptor and Cysteine Redox Dynamics Underlie (Mal)adaptive Mechanisms to Chronic Intermittent Hypoxia in Kidney Cortex". Antioxidants 10 9 (2021): 1484. http://dx.doi.org/10.3390/antiox10091484.
    Publicado • 10.3390/antiox10091484
  11. Martins, Fátima O.; Sacramento, Joana F.; Olea, Elena; Melo, Bernardete F.; Prieto-Lloret, Jesus; Obeso, Ana; Rocher, Asuncion; et al. "Chronic Intermittent Hypoxia Induces Early-Stage Metabolic Dysfunction Independently of Adipose Tissue Deregulation". Antioxidants 10 8 (2021): 1233. http://dx.doi.org/10.3390/antiox10081233.
    Publicado • 10.3390/antiox10081233
  12. Marto, Natalia; Morello, Judit; Antunes, Alexandra; Monteiro, Emília; Pereira, Sofia. "Phenotyping SULT in Man: a Simple Metric Using Paracetamol as Probe". The FASEB Journal 35 S1 (2021): http://dx.doi.org/10.1096/fasebj.2021.35.s1.03064.
    Publicado • 10.1096/fasebj.2021.35.s1.03064
  13. Marto, Natália; Morello, Judit; Antunes, Alexandra M. M.; Azeredo, Sofia; Monteiro, Emília C.; Pereira, Sofia A.. "A simple method to measure sulfonation in man using paracetamol as probe drug". Scientific Reports 11 1 (2021): http://dx.doi.org/10.1038/s41598-021-88393-3.
    10.1038/s41598-021-88393-3
  14. Marinho, Aline T.; Batuca, Joana R.; Miranda, Joana P.; Caixas, Umbelina; Dias, Clara G.; Branco, Teresa; Soto, Karina; et al. "The 2-hydroxy-nevirapine metabolite as a candidate for boosting apolipoprotein A1 and for modulating anti-HDL antibodies". Pharmacological Research (2021): 105446. http://dx.doi.org/10.1016/j.phrs.2021.105446.
    10.1016/j.phrs.2021.105446
  15. Coelho, Nuno R.; Matos, Clara; Pimpão, António B.; Correia, M. João; Sequeira, Catarina O.; Morello, Judit; Pereira, Sofia A.; Monteiro, Emília C.. "AHR canonical pathway: in vivo findings to support novel antihypertensive strategies". Pharmacological Research (2021): 105407. http://dx.doi.org/10.1016/j.phrs.2020.105407.
    10.1016/j.phrs.2020.105407
  16. Brinkman DJ; Monteiro T; Monteiro EC; Richir MC; van Agtmael MA; Tichelaar J. "Switching from a traditional undergraduate programme in (clinical) pharmacology and therapeutics to a problem-based learning programme.". European journal of clinical pharmacology (2020): http://europepmc.org/abstract/med/33098019.
    10.1007/s00228-020-03027-3
  17. Helena Pite; Laura Aguiar; Judit Morello; Emilia Monteiro; Ana Catarina Alves; Mafalda Bourbon; Mário Morais-Almeida. "

    Metabolic Dysfunction and Asthma: Current Perspectives

    ". Journal of Asthma and Allergy (2020): https://doi.org/10.2147/JAA.S208823.
    10.2147/JAA.S208823
  18. Marto N; Monteiro EC. "Medicines for the Treatment Of COVID-19: Awaiting the Evidence.". Acta medica portuguesa (2020): http://europepmc.org/abstract/med/32425152.
    10.20344/amp.13908
  19. Coelho NR; Tomkiewicz C; Correia MJ; Gonçalves-Dias C; Barouki R; Pereira SA; Coumoul X; Monteiro EC. "First evidence of aryl hydrocarbon receptor as a druggable target in hypertension induced by chronic intermittent hypoxia.". Pharmacological research (2020): http://europepmc.org/abstract/med/32416216.
    10.1016/j.phrs.2020.104869
  20. Magnin, Annette; Iversen, Valentina Cabral; Calvo, Gonzalo; Cecetková, Beata; Dale, Ola; Demlová, Regina; Blaskó, György; et al. "European survey on national harmonization in clinical research". Learning Health Systems 5 2 (2020): http://dx.doi.org/10.1002/lrh2.10220.
    Publicado • 10.1002/lrh2.10220
  21. Magnin, A.; Iversen, V. Cabral; Calvo, G.; Cecetková, B.; Dale, O.; Demlova, R.; Blasko, Gy.; et al. "European survey on national training activities in clinical research". Trials 20 1 (2019): http://dx.doi.org/10.1186/s13063-019-3702-z.
    10.1186/s13063-019-3702-z
  22. Joana F. Sacramento; Elena Olea; Maria J. Ribeiro; Jesus Prieto-Lloret; Bernardete F. Melo; Constancio Gonzalez; Fatima O. Martins; Emilia C. Monteiro; Silvia V. Conde. "Contribution of adenosine and ATP to the carotid body chemosensory activity in ageing". The Journal of Physiology (2019): https://doi.org/10.1113/JP274179.
    10.1113/JP274179
  23. Monteiro, Maria. "Appropriate antibiotic prescribing among final-year medical students in Europe". International Journal of Antimicrobial Agents (2019): http://dx.doi.org/10.1016/j.ijantimicag.2019.05.008.
    10.1016/j.ijantimicag.2019.05.008
  24. Monteiro, Maria. "Transparency and accuracy in funding investigator-initiated clinical trials: a systematic search in clinical trials databases". BMJ Open (2019): http://dx.doi.org/10.1136/bmjopen-2018-023394.
    10.1136/bmjopen-2018-023394
  25. Gonçalves-Dias; Morello; Semedo; Correia; Coelho; Monteiro; Antunes; Pereira. "The mercapturomic profile of health and non-communicable diseases". High-Throughput 8 2 (2019): 10-10. https://doi.org/10.3390/ht8020010.
    10.3390/ht8020010
  26. Monteiro, Maria. "Mercapturate Pathway in the Tubulocentric Perspective of Diabetic Kidney Disease". Nephron (2019): http://dx.doi.org/10.1159/000494390.
    10.1159/000494390
  27. Aline T. Marinho; Joana P. Miranda; Umbelina Caixas; Catarina Charneira; Clara Gonçalves-Dias; M. Matilde Marques; Emília C. Monteiro; Alexandra M. M. Antunes; Sofia A. Pereira. "Singularities of nevirapine metabolism: from sex-dependent differences to idiosyncratic toxicity". Drug Metabolism Reviews 51 1 (2019): 76-90. https://doi.org/10.1080/03602532.2019.1577891.
    10.1080/03602532.2019.1577891
  28. Morello, Judit; Derks, Rico J. E.; Lopes, Susana S.; Steenvoorden, Evelyne; Monteiro, Emilia C.; Mayboroda, Oleg A.; Pereira, Sofia A.. "Zebrafish Larvae Are a Suitable Model to Investigate the Metabolic Phenotype of Drug-Induced Renal Tubular Injury". Frontiers in Pharmacology 9 (2018): http://dx.doi.org/10.3389/fphar.2018.01193.
    10.3389/fphar.2018.01193
  29. Brinkman DJ; Tichelaar J; Mokkink LB; Christiaens T; Likic R; Maciulaitis R; Costa J; et al. "Key learning outcomes for clinical pharmacology and therapeutics education in Europe: A modified Delphi study.". Clinical pharmacology and therapeutics (2017): http://europepmc.org/abstract/med/29205299.
    10.1002/cpt.962
  30. Gorgulho R; Jacinto R; Lopes SS; Pereira SA; Tranfield EM; Martins GG; Gualda EJ; et al. "Usefulness of zebrafish larvae to evaluate drug-induced functional and morphological renal tubular alterations.". Archives of toxicology (2017): http://europepmc.org/abstract/med/28932931.
    10.1007/s00204-017-2063-1
  31. Marto N; Morello J; Monteiro EC; Pereira SA. "Implications of sulfotransferase activity in interindividual variability in drug response: clinical perspective on current knowledge.". Drug metabolism reviews (2017): http://europepmc.org/abstract/med/28554218.
    10.1080/03602532.2017.1335749
  32. Grilo NM; João Correia M; Miranda JP; Cipriano M; Serpa J; Matilde Marques M; Monteiro EC; et al. "Unmasking efavirenz neurotoxicity: Time matters to the underlying mechanisms.". European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (2017): http://europepmc.org/abstract/med/28487145.
    10.1016/j.ejps.2017.05.010
  33. Brinkman DJ; Tichelaar J; Schutte T; Benemei S; Böttiger Y; Chamontin B; Christiaens T; et al. "Essential competencies in prescribing: A first european cross-sectional study among 895 final-year medical students.". Clinical pharmacology and therapeutics (2017): http://europepmc.org/abstract/med/27648725.
    10.1002/cpt.521
  34. Conde SV; Monteiro EC; Sacramento JF. "Purines and Carotid Body: New Roles in Pathological Conditions.". Frontiers in pharmacology (2017): http://europepmc.org/abstract/med/29311923.
    10.3389/fphar.2017.00913
  35. Grilo NM; Correia MJ; Sequeira C; Harjivan SG; Caixas U; Diogo LN; Marques MM; et al. "Efavirenz biotransformation as an up-stream event of mood changes in HIV-infected patients.". Toxicology letters (2016): http://europepmc.org/abstract/med/27543169.
    10.1016/j.toxlet.2016.08.009
  36. Pedroso D; Nunes AR; Diogo LN; Oudot C; Monteiro EC; Brenner C; Vieira HLA. "Hippocampal neurogenesis response: What can we expect from two different models of hypertension?". Brain research (2016): http://europepmc.org/abstract/med/27235865.
    10.1016/j.brainres.2016.05.044
  37. Vera-Cruz P; Rito M; Diogo L; Zagalo C; Dos Santos JM; Monteiro ME. "Structure of the rat tracheal mucosa after chronic intermittent hypoxia or chronic hyperbaric oxygen therapy.". (2016): http://europepmc.org/abstract/med/26648111.
    10.14670/HH-11-703
  38. Sacramento JF; Ribeiro MJ; Rodrigues T; Guarino MP; Diogo LN; Seiça R; Monteiro EC; Matafome P; Conde SV. "Insulin resistance is associated with tissue-specific regulation of HIF-1a and HIF-2a during mild chronic intermittent hypoxia.". (2016): http://europepmc.org/abstract/med/26993367.
    10.1016/j.resp.2016.03.007
  39. Alvarez-Martins I; Remédio L; Matias I; Diogo LN; Monteiro EC; Dias S; Alvarez-Martins, I.; et al. "The impact of chronic intermittent hypoxia on hematopoiesis and the bone marrow microenvironment.". Pflugers Archiv European Journal of Physiology 468 5 (2016): 919-932. http://europepmc.org/abstract/med/26856724.
    10.1007/s00424-016-1797-6
  40. Marinho AT; Dias CG; Pinheiro PF; Lemos AR; Antunes AM; Marques MM; Monteiro EC; Miranda JP; Pereira SA. "Nevirapine modulation of paraoxonase-1 in the liver: An in vitro three-model approach.". (2016): http://europepmc.org/abstract/med/26620700.
    10.1016/j.ejps.2015.11.019
  41. Madeira, C.; Pais, A.; Kubiak, C.; Demotes, J.; Monteiro, E.C.. "Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN)". Contemporary Clinical Trials Communications 4 (2016): 141-148. http://www.scopus.com/inward/record.url?eid=2-s2.0-84986253551&partnerID=MN8TOARS.
    10.1016/j.conctc.2016.08.002
  42. Diogo LN; Pereira SA; Nunes AR; Afonso RA; Santos AI; Monteiro EC. "Efficacy of carvedilol in reversing hypertension induced by chronic intermittent hypoxia in rats.". (2015): http://europepmc.org/abstract/med/26291659.
    10.1016/j.ejphar.2015.08.019
  43. Diogo LN; Faustino IV; Afonso RA; Pereira SA; Monteiro EC; Santos AI. "Voluntary Oral Administration of Losartan in Rats.". (2015): http://europepmc.org/abstract/med/26424254.
  44. Diogo LN; Pinto P; Bárbara C; Monteiro EC; Papoila AL. "Neck circumference and body mass index as independent predictors of hypertension misclassification in patients suspected of having obstructive sleep apnea.". (2015): http://europepmc.org/abstract/med/25121756.
    10.1097/MBP.0000000000000080
  45. Diogo, L.N.; Faustino, I.V.; Afonso, R.A.; Pereira, S.A.; Monteiro, E.C.; Santos, A.I.. "Voluntary oral administration of losartan in rats". Journal of the American Association for Laboratory Animal Science 54 5 (2015): 549-556. http://www.scopus.com/inward/record.url?eid=2-s2.0-84943195739&partnerID=MN8TOARS.
  46. Diogo LN; Pinto P; Bárbara C; Papoila AL; Monteiro EC. "The Association Between Antihypertensive Medication and Blood Pressure Control in Patients with Obstructive Sleep Apnea.". (2015): http://europepmc.org/abstract/med/26303482.
    10.1007/978-3-319-18440-1_22
  47. Nunes AR; Monteiro E; Gauda E. "Soluble adenylyl cyclase in the locus coeruleus.". (2014): http://europepmc.org/abstract/med/24973474.
    10.1016/j.resp.2014.05.011
  48. Grilo NM; Charneira C; Pereira SA; Monteiro EC; Marques MM; Antunes AM. "Bioactivation to an aldehyde metabolite--possible role in the onset of toxicity induced by the anti-HIV drug abacavir.". (2014): http://europepmc.org/abstract/med/24211422.
    10.1016/j.toxlet.2013.10.036
  49. Dias C; Marinho A; Morello J; Almeida G; Caixas U; Soto K; Monteiro E; Pereira S. "Monitoring of the lactonase activity of paraoxonase-1 enzyme in HIV-1-infection.". (2014): http://europepmc.org/abstract/PMC/PMC4225321.
    10.7448/IAS.17.4.19682
  50. Marinho A; Dias C; Antunes A; Caixas U; Branco T; Marques M; Monteiro E; Pereira S. "Sex differences in apolipoprotein A1 and nevirapine-induced toxicity.". (2014): http://europepmc.org/abstract/med/25394082.
    10.7448/IAS.17.4.19575
  51. Nunes AR; Holmes AP; Conde SV; Gauda EB; Monteiro EC. "Revisiting cAMP signaling in the carotid body.". (2014): http://europepmc.org/abstract/med/25389406.
    10.3389/fphys.2014.00406
  52. Diogo LN; Monteiro EC. "The efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions.". (2014): http://europepmc.org/abstract/med/25295010.
    10.3389/fphys.2014.00361
  53. Conde SV; Sacramento JF; Guarino MP; Gonzalez C; Obeso A; Diogo LN; Monteiro EC; Ribeiro MJ. "Carotid body, insulin, and metabolic diseases: unraveling the links.". (2014): http://europepmc.org/abstract/med/25400585.
    10.3389/fphys.2014.00418
  54. Dias, C.G.; Batuca, J.R.; Marinho, A.T.; Caixas, U.; Monteiro, E.C.; Antunes, A.M.M.; Pereira, S.A.. "Quantification of the arylesterase activity of paraoxonase-1 in human blood". Analytical Methods 6 1 (2014): 289-294. http://www.scopus.com/inward/record.url?eid=2-s2.0-84890071175&partnerID=MN8TOARS.
    10.1039/c3ay41527a
  55. Marinho, A.T.; Godinho, A.L.A.; Novais, D.A.; Antunes, A.M.M.; Marques, M.M.; Ramos, T.; Dias, C.G.; Monteiro, E.C.; Pereira, S.A.. "Development and validation of an HPLC-UV method for quantifying nevirapine and its main phase i metabolites in human blood". Analytical Methods 6 5 (2014): 1575-1580. http://www.scopus.com/inward/record.url?eid=2-s2.0-84894120111&partnerID=MN8TOARS.
    10.1039/c3ay41911h
  56. Marinho, A. T.; Rodrigues, P. M.; Caixas, U.; Antunes, A. M. M.; Branco, T.; Harjivan, S. G.; Marques, M. M.; Monteiro, E. C.; Pereira, S. A.. "Differences in nevirapine biotransformation as a factor for its sex-dependent dimorphic profile of adverse drug reactions". Journal of Antimicrobial Chemotherapy 69 2 (2013): 476-482. http://dx.doi.org/10.1093/jac/dkt359.
    10.1093/jac/dkt359
  57. Ribeiro MJ; Sacramento JF; Gonzalez C; Guarino MP; Monteiro EC; Conde SV. "Carotid body denervation prevents the development of insulin resistance and hypertension induced by hypercaloric diets.". (2013): http://europepmc.org/abstract/med/23530003.
    10.2337/db12-1463
  58. Grilo, N.M.; Antunes, A.M.M.; Caixas, U.; Marinho, A.T.; Charneira, C.; Conceição Oliveira, M.; Monteiro, E.C.; Matilde Marques, M.; Pereira, S.A.. "Monitoring abacavir bioactivation in humans: Screening for an aldehyde metabolite". Toxicology Letters 219 1 (2013): 59-64. http://www.scopus.com/inward/record.url?eid=2-s2.0-84875885900&partnerID=MN8TOARS.
    10.1016/j.toxlet.2013.02.021
  59. Nunes, A.R.; Holmes, A.P.S.; Sample, V.; Kumar, P.; Cann, M.J.; Monteiro, E.C.; Zhang, J.; Gauda, E.B.. "Bicarbonate-sensitive soluble and transmembrane adenylyl cyclases in peripheral chemoreceptors". Respiratory Physiology and Neurobiology 188 2 (2013): 83-93. http://www.scopus.com/inward/record.url?eid=2-s2.0-84880100523&partnerID=MN8TOARS.
    10.1016/j.resp.2013.05.013
  60. Charneira, C.; Grilo, N.M.; Pereira, S.A.; Godinho, A.L.A.; Monteiro, E.C.; Marques, M.M.; Antunes, A.M.M.. "N-terminal valine adduct from the anti-HIV drug abacavir in rat haemoglobin as evidence for abacavir metabolism to a reactive aldehyde in vivo". British Journal of Pharmacology 167 6 (2012): 1353-1361. http://www.scopus.com/inward/record.url?eid=2-s2.0-84867773600&partnerID=MN8TOARS.
    10.1111/j.1476-5381.2012.02079.x
  61. Nunes AR; Sample V; Xiang YK; Monteiro EC; Gauda E; Zhang J; Nunes, A.R.; et al. "Effect of oxygen on phosphodiesterases (PDE) 3 and 4 isoforms and PKA activity in the superior cervical ganglia.". Advances in Experimental Medicine and Biology 758 (2012): 287-294. http://europepmc.org/abstract/med/23080174.
    10.1007/978-94-007-4584-1_39
  62. Conde SV; Obeso A; Monteiro EC; Gonzalez C; Conde, S.V.; Obeso, A.; Monteiro, E.C.; Gonzalez, C.. "Effect of chronic caffeine intake on carotid body catecholamine dynamics in control and chronically hypoxic rats.". Advances in Experimental Medicine and Biology 758 (2012): 315-323. http://europepmc.org/abstract/med/23080178.
    10.1007/978-94-007-4584-1_43
  63. Caixas, U.; Antunes, A.M.M.; Marinho, A.T.; Godinho, A.L.A.; Grilo, N.M.; Marques, M.M.; Oliveira, M.C.; et al. "Evidence for nevirapine bioactivation in man: Searching for the first step in the mechanism of nevirapine toxicity". Toxicology 301 1-3 (2012): 33-39. http://www.scopus.com/inward/record.url?eid=2-s2.0-84864807069&partnerID=MN8TOARS.
    10.1016/j.tox.2012.06.013
  64. Conde, S.V.; Ribeiro, M.J.; Obeso, A.; Rigual, R.; Monteiro, E.C.; Gonzalez, C.. "Chronic caffeine intake in adult rat inhibits carotid body sensitization produced by chronic sustained hypoxia but maintains intact chemoreflex output". Molecular Pharmacology 82 6 (2012): 1056-1065. http://www.scopus.com/inward/record.url?eid=2-s2.0-84869858797&partnerID=MN8TOARS.
    10.1124/mol.112.081216
  65. Conde, S.V.; Nunes Da Silva, T.; Gonzalez, C.; Mota Carmo, M.; Monteiro, E.C.; Guarino, M.P.. "Chronic caffeine intake decreases circulating catecholamines and prevents diet-induced insulin resistance and hypertension in rats". British Journal of Nutrition 107 1 (2012): 86-95. http://www.scopus.com/inward/record.url?eid=2-s2.0-84855787744&partnerID=MN8TOARS.
    10.1017/S0007114511002406
  66. Conde, S.V.; Monteiro, E.C.; Rigual, R.; Obeso, A.; Gonzalez, C.. "Hypoxic intensity: A determinant for the contribution of ATP and adenosine to the genesis of carotid body chemosensory activity". Journal of Applied Physiology 112 12 (2012): 2002-2010. http://www.scopus.com/inward/record.url?eid=2-s2.0-84862579463&partnerID=MN8TOARS.
    10.1152/japplphysiol.01617.2011
  67. Pereira, S.A.; Wanke, R.; Marques, M.M.; Monteiro, E.C.; Antunes, A.M.M.. "Insights into the role of bioactivation mechanisms in the toxic events elicited by non-nucleoside reverse transcriptase inhibitors". Advances in Molecular Toxicology 6 (2012): 1-39. http://www.scopus.com/inward/record.url?eid=2-s2.0-84865355478&partnerID=MN8TOARS.
    10.1016/B978-0-444-59389-4.00001-X
  68. Caixas, U.; Ferreira, J.; Marinho, A.T.; Faustino, I.; Grilo, N.M.; Lampreia, F.; Germano, I.; Monteiro, E.C.; Pereira, S.A.. "Long-term maraviroc use as salvage therapy in HIV-2 infection". Journal of Antimicrobial Chemotherapy 67 10 (2012): 2538-2539. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866613168&partnerID=MN8TOARS.
    10.1093/jac/dks240
  69. Monteiro, T.C.; Batuca, J.R.; Obeso, A.; González, C.; Monteiro, E.C.. "Carotid body function in aged rats: Responses to hypoxia, ischemia, dopamine, and adenosine". Age 33 3 (2011): 337-350. http://www.scopus.com/inward/record.url?eid=2-s2.0-80655145960&partnerID=MN8TOARS.
    10.1007/s11357-010-9187-z
  70. Charneira, C.; Godinho, A.L.A.; Oliveira, M.C.; Pereira, S.A.; Monteiro, E.C.; Marques, M.M.; Antunes, A.M.M.. "Reactive aldehyde metabolites from the anti-HIV drug abacavir: Amino acid adducts as possible factors in abacavir toxicity". Chemical Research in Toxicology 24 12 (2011): 2129-2141. http://www.scopus.com/inward/record.url?eid=2-s2.0-84055218870&partnerID=MN8TOARS.
    10.1021/tx200337b
  71. Nunes, A.R.; Batuca, J.R.; Monteiro, E.C.. "Acute hypoxia modifies cAMP levels induced by inhibitors of phosphodiesterase-4 in rat carotid bodies, carotid arteries and superior cervical ganglia". British Journal of Pharmacology 159 2 (2010): 353-361. http://www.scopus.com/inward/record.url?eid=2-s2.0-75649134184&partnerID=MN8TOARS.
    10.1111/j.1476-5381.2009.00534.x
  72. Pereira, S. A.; Batuca, J. R.; Caixas, U.; Branco, T.; Delgado-Alves, J.; Germano, I.; Lampreia, F.; Monteiro, E. C.. "Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients". British Journal of Clinical Pharmacology 68 6 (2009): 891-897. http://dx.doi.org/10.1111/j.1365-2125.2009.03535.x.
    10.1111/j.1365-2125.2009.03535.x
  73. Conde, S.V.; Obeso, A.; Monteiro, E.C.; Gonzalez, C.. "The A 2B-D 2 receptor interaction that controls carotid body catecholamines release locates between the last two steps of hypoxic transduction cascade". Advances in Experimental Medicine and Biology 648 (2009): 161-168. http://www.scopus.com/inward/record.url?eid=2-s2.0-67651205673&partnerID=MN8TOARS.
    10.1007/978-90-481-2259-2_18
  74. Conde, S.V.; Monteiro, E.C.; Obeso, A.; Gonzalez, C.. "Adenosine in peripheral chemoreception: New insights into a historically overlooked molecule". Advances in Experimental Medicine and Biology 648 (2009): 145-159. http://www.scopus.com/inward/record.url?eid=2-s2.0-67651205671&partnerID=MN8TOARS.
    10.1007/978-90-481-2259-2_17
  75. Nunes, A.R.; Batuca, J.R.; Monteiro, E.C.. "Functional characterization of phosphodiesterases 4 in the rat carotid body: Effect of oxygen concentrations". Advances in Experimental Medicine and Biology 648 (2009): 113-119. http://www.scopus.com/inward/record.url?eid=2-s2.0-67651219181&partnerID=MN8TOARS.
    10.1007/978-90-481-2259-2_13
  76. Nunes, A.R.; Monteiro, E.C.; Johnson, S.M.; Gauda, E.B.. "Bicarbonate-regulated soluble adenylyl cyclase (sAC) mRNA expression and activity in peripheral chemoreceptors". Advances in Experimental Medicine and Biology 648 (2009): 235-241. http://www.scopus.com/inward/record.url?eid=2-s2.0-67651207741&partnerID=MN8TOARS.
    10.1007/978-90-481-2259-2_27
  77. Monteiro, T.C.; Obeso, A.; Gonzalez, C.; Monteiro, E.C.. "Does ageing modify ventilatory responses to dopamine in anaesthetised rats breathing spontaneously?". Advances in Experimental Medicine and Biology 648 (2009): 265-271. http://www.scopus.com/inward/record.url?eid=2-s2.0-67651205663&partnerID=MN8TOARS.
    10.1007/978-90-481-2259-2_30
  78. Pereira, S.A.; Branco, T.; Caixas, U.; Côrte-Real, R.M.; Germano, I.; Lampreia, F.; Monteiro, E.C.. "Intra-individual variability in efavirenz plasma concentrations supports therapeutic drug monitoring based on quarterly sampling in the first year of therapy". Therapeutic Drug Monitoring 30 1 (2008): 60-66. http://www.scopus.com/inward/record.url?eid=2-s2.0-38549087038&partnerID=MN8TOARS.
    10.1097/FTD.0b013e318160ce76
  79. Pereira, S.A.; Caixas, U.; Branco, T.; Germano, I.; Lampreia, F.; Papoila, A.L.; Monteiro, E.C.. "Efavirenz concentrations in HIV-infected patients with and without viral hepatitis". British Journal of Clinical Pharmacology 66 4 (2008): 551-555. http://www.scopus.com/inward/record.url?eid=2-s2.0-51649096977&partnerID=MN8TOARS.
    10.1111/j.1365-2125.2008.03238.x
  80. Conde, S.V.; Gonzalez, C.; Batuca, J.R.; Monteiro, E.C.; Obeso, A.. "An antagonistic interaction between A2B adenosine and D 2 dopamine receptors modulates the function of rat carotid body chemoreceptor cells". Journal of Neurochemistry 107 5 (2008): 1369-1381. http://www.scopus.com/inward/record.url?eid=2-s2.0-55849129304&partnerID=MN8TOARS.
    10.1111/j.1471-4159.2008.05704.x
  81. Pereira, SA; Batuca, J; Caixas, U; Branco, T; Germano, I; Lampreia, F; Delgado-Alves, J; Monteiro, EC. "HIV and antioxidant lipoprotein-associated effect. Is there a correlation?". Journal of the International AIDS Society 11 Suppl 1 (2008): P96-P96. http://dx.doi.org/10.1186/1758-2652-11-S1-P96.
    10.1186/1758-2652-11-s1-p96
  82. Conde, S.V.; Monteiro, E.C.. "Activation of nicotinic ACh receptors with a4 subunits induces adenosine release at the rat carotid body". British Journal of Pharmacology 147 7 (2006): 783-789. http://www.scopus.com/inward/record.url?eid=2-s2.0-33645547406&partnerID=MN8TOARS.
    10.1038/sj.bjp.0706676
  83. Pereira, S.A.; Branco, T.; Côrte-Real, R.M.; Germano, I.; Lampreia, F.; Caixas, U.; Monteiro, E.C.. "Long-term and concentration-dependent beneficial effect of efavirenz on HDL-cholesterol in HIV-infected patients". British Journal of Clinical Pharmacology 61 5 (2006): 601-604. http://www.scopus.com/inward/record.url?eid=2-s2.0-33646265773&partnerID=MN8TOARS.
    10.1111/j.1365-2125.2006.02619.x
  84. Conde, S.V.; Obeso, A.; Rigual, R.; Monteiro, E.C.; Gonzalez, C.. "Function of the rat carotid body chemoreceptors in ageing". Journal of Neurochemistry 99 3 (2006): 711-723. http://www.scopus.com/inward/record.url?eid=2-s2.0-33750080433&partnerID=MN8TOARS.
    10.1111/j.1471-4159.2006.04094.x
  85. Conde SV; Monteiro EC. "Profiles for ATP and adenosine release at the carotid body in response to O2 concentrations.". (2006): http://europepmc.org/abstract/med/16683716.
  86. Conde, S.V.; Monteiro, E.C.. "Profiles for ATP and adenosine release at the carotid body in response to O2 concentrations.". Advances in experimental medicine and biology. 580 (2006): http://www.scopus.com/inward/record.url?eid=2-s2.0-33745233081&partnerID=MN8TOARS.
  87. Conde, S.V.; Monteiro, E.C.. "Profiles for ATP and adenosine release at the carotid body in response to O2 concentrations". Advances in Experimental Medicine and Biology 580 (2006): 179-184. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745233081&partnerID=MN8TOARS.
    10.1007/0-387-31311-7-27
  88. Conde, S.V.; Monteiro, E.C.. "Hypoxia induces adenosine release from the rat carotid body". Journal of Neurochemistry 89 5 (2004): 1148-1156. http://www.scopus.com/inward/record.url?eid=2-s2.0-2642526852&partnerID=MN8TOARS.
    10.1111/j.1471-4159.2004.02380.x
  89. Batuca JR; Monteiro TC; Monteiro EC. "Contribution of dopamine D2 receptors for the cAMP levels at the carotid body.". (2003): http://europepmc.org/abstract/med/14635690.
  90. Conde SV; Monteiro EC. "Adenosine-acetylcholine interactions at the rat carotid body.". (2003): http://europepmc.org/abstract/med/14635682.
  91. Conde, S.V.; Monteiro, E.C.. "Adenosine-Acetylcholine Interactions at the Rat Carotid Body". Advances in Experimental Medicine and Biology 536 (2002): 305-311. http://www.scopus.com/inward/record.url?eid=2-s2.0-0344688361&partnerID=MN8TOARS.
  92. Batuca, J.R.; Monteiro, T.C.; Monteiro, E.C.. "Contribution of Dopamine D2 Receptors for the cAMP Levels at the Carotid Body". Advances in Experimental Medicine and Biology 536 (2002): 367-373. http://www.scopus.com/inward/record.url?eid=2-s2.0-3543138433&partnerID=MN8TOARS.
  93. Monteiro EC; Ribeiro JA. "Adenosine-dopamine interactions and ventilation mediated through carotid body chemoreceptors.". (2000): http://europepmc.org/abstract/med/10849708.
  94. Monteiro, E.C.; Ribeiro, J.A.. "Adenosine-dopamine interactions and ventilation mediated through carotid body chemoreceptors". Advances in Experimental Medicine and Biology 475 (2000): 671-684. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034465679&partnerID=MN8TOARS.
  95. Monteiro EC; Vera-Cruz P; Monteiro TC; Silva e Sousa MA. "Adenosine increases the cAMP content of the rat carotid body in vitro.". (1996): http://europepmc.org/abstract/med/9030315.
  96. Monteiro, E.C.; Vera-Cruz, P.; Monteiro, T.C.; Silva E Sousa, M.A.. "Adenosine increases the cAMP content of the rat carotid body in vitro". Advances in Experimental Medicine and Biology 410 (1996): 299-303. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030452543&partnerID=MN8TOARS.
  97. Monteiro EC; Ribeiro JA; Monteiro, E.C.; Ribeiro, J.A.. "Adenosine and the bradycardiac response to vagus nerve stimulation in rats.". European Journal of Pharmacology 204 2 (1991): 193-202. http://europepmc.org/abstract/med/1806387.
    10.1016/0014-2999(91)90705-U
  98. Monteiro, E.C.; Ribeiro, J.A.. "Involvement of adenosine during stimulation of ventilation induced by common carotid occlusion". Revista Portuguesa de Hemorreologia 5 2 (1991): 249-254. http://www.scopus.com/inward/record.url?eid=2-s2.0-0025950467&partnerID=MN8TOARS.
  99. Ribeiro, J.A.; Monteiro, E.C.. "On the adenosine receptor involved in the excitatory action of adenosine on respiration: Antagonist profile". Nucleosides and Nucleotides 10 5 (1991): 945-953. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026005936&partnerID=MN8TOARS.
    10.1080/07328319108047232
  100. Monteiro EC; Ribeiro JA; Monteiro, E.C.; Ribeiro, J.A.. "Adenosine deaminase and adenosine uptake inhibitions facilitate ventilation in rats.". Naunyn-Schmiedeberg's Archives of Pharmacology 340 2 (1989): 230-238. http://europepmc.org/abstract/med/2812035.
    10.1007/BF00168974
  101. Monteiro, E.C.; Ribeiro, J.A.; Monteiro EC; Ribeiro JA. "Inhibition by 1,3-dipropyl-8(p-sulfophenyl)xanthine of the respiratory stimulation induced by common carotid occlusion in rats". Life Sciences 45 10 (1989): 939-945. http://www.scopus.com/inward/record.url?eid=2-s2.0-0024453848&partnerID=MN8TOARS.
    10.1016/0024-3205(89)90208-7
  102. Monteiro, E.C.; Ribeiro, J.A.; Monteiro EC; Ribeiro JA. "Ventilatory effects of adenosine mediated by carotid body chemoreceptors in the rat". Naunyn-Schmiedeberg's Archives of Pharmacology 335 2 (1987): 143-148. http://www.scopus.com/inward/record.url?eid=2-s2.0-0023102955&partnerID=MN8TOARS.
    10.1007/BF00177715
Capítulo de livro
  1. Pimpão, António B.; Sousa, Cátia; Correia, Maria J.; Coelho, Nuno R.; Monteiro, Emília C.; Melo Junior, Antonio F.; Pereira, Sofia A.. "Control of Arterial Hypertension by the AhR Blocker CH-223191: A Chronopharmacological Study in Chronic Intermittent Hypoxia Conditions". In Advances in Experimental Medicine and Biology, 35-42. Springer International Publishing, 2023.
    10.1007/978-3-031-32371-3_4
  2. Gonçalves-Dias, Clara; Sequeira, Catarina O.; Vicente, João B.; Correia, M. João; Coelho, Nuno R.; Morello, Judit; Antunes, Alexandra M. M.; et al. "A Mechanistic-Based and Non-invasive Approach to Quantify the Capability of Kidney to Detoxify Cysteine-Disulfides". In Advances in Experimental Medicine and Biology, 109-120. Springer International Publishing, 2021.
    Publicado • 10.1007/978-3-030-63908-2_8
  3. Isabel Faro de Albuquerque; Catarina Martins Lopes; Nuno Lourenço-Silva; José Fragata; Monteiro, EC. "Which medical professional?". In From Life Molecules to Global Health, 620-632. PRINCIPIA, 2021.
    Publicado
  4. João Filipe Raposo; José A. Belo; Sílvia V. Conde; Monteiro, EC; José Silva Nunes; Pereira, Sofia A.; Gabriela A. Silva; Maria Paula Macedo. "B FROM A CLASSICAL TO A NEW NOVA PERSPECTIVE ON CARDIOMETABOLIC DISEASES". In From Life Molecules to Global Health, 261-290. PRINCIPIA, 2021.
    Publicado
  5. Clara Gonçalves-Dias; Catarina O. Sequeira; João B. Vicente; Maria João Correia; Coelho, NR; Morello, Judit; Antunes, Alexandra; et al. "A Mechanistic-Based and Non-Invasive Approach to Quantify the Capability of Kidney to Detoxify Cysteine-Disulfide". In Urinomics. Springer International Publishing AG, 2020.
    No prelo
  6. Coelho, Nuno R.; Dias, Clara G.; João Correia, M.; Grácio, Patrícia; Serpa, Jacinta; Monteiro, Emília C.; Diogo, Lucília N.; Pereira, Sofia A.. "Cysteine Oxidative Dynamics Underlies Hypertension and Kidney Dysfunction Induced by Chronic Intermittent Hypoxia". In Advances in Experimental Medicine and Biology, 83-88. Springer International Publishing, 2018.
    10.1007/978-3-319-91137-3_10
  7. Monteiro, EC. "Understanding the molecular basis for the hazards associated with Nevirapine treatment". In Advances in Medicine and Biology, 77-100. Nova Science Publishers, 2012.
  8. CONDE, SÍLVIA V.; MONTEIRO, EMÍLIA C.. "Profiles for ATP and Adenosine Release at the Carotid Body in Response to O2 Concentrations". In ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 179-184. Springer US, 2006.
    10.1007/0-387-31311-7_27
  9. Monteiro, EC. "Perfil Farmacológico dos fármacos agonistas dos receptores B2. Em: Agonistas dos receptores B2". In Curso Interactivo de Pneumologia, 719. Permanyer Portugal, 2002.
  10. Monteiro, EC. "Endogenous adenosine tonically excites respiration mediated through carotid body chemoreceptors in the rat". In Arterial Chemoreception, 174-180. Springer Verlag, New York, 1990.
  11. Monteiro, EC. "Respiratory responses to common carotid occlusion in the rat: evidence for involvement of adenosine". In Chemoreceptors and Chemoreceptor reflexes, 49-56. Plenum Press, New York, 1990.
  12. Monteiro, EC. "The actions of adenosine on respiration". In Physiology and Pharmacology of Adenosine and Adenine nucleotides, 225-232. Taylor and Francis, Ltd, London, 1988.
  13. Monteiro, EC. "Adenosine modulation of respiration mediated by carotid body chemoreceptors". In Chemoreceptors and Respiratory Control, 314-320. Croom Helm, London, 1987.
  14. Monteiro, EC. "Fisiologia de la Tos". In Libro de Homenaje al Prof. Ortiz de Landazuri. Garsi, Madrid, 1984.
Poster em conferência
  1. António B. Pimpão; Correia, M João; Mecha, Elsa; Sequeira O. C.; FERNANDES, DALILA; Ana Teresa Serra; Silva, Sandra; et al. Autor correspondente: Pereira, Sofia. "OHTyr Mitigates CIH-induced Hypertension: AhR Signaling and Cysteine Pathways". Trabalho apresentado em European Respiratory Society (ERS) Research Seminar - Sleep apnoea and its consequences: from animal models to precision medicine, 2024.
  2. Monteiro, EC; Coelho, Nuno; Tomkiewcz, Céline; Correia, M João; Pimpão, António; Barouki, Robert; Coumoul, Xavier; Pereira, Sofia A.. "P19-ARYL HYDROCARBON RECEPTOR ANTAGONISTS - A NEW ENTRY IN ANTIHYPERTENSIVE ARMAMENTARIUM OF OBSTRUCTIVE SLEEP APNEA?". Trabalho apresentado em ESH-ISH Joint Meeting - Hypertension meeting participation, 2021.
  3. Dalila G. H. Fernandes; Coelho, Nuno; Correia, M João; Tomé C.S.; Sequeira CO; Monteiro, EC; Pereira, Sofia A.; Vicente, João B.. "The six W´s of protein cysteinylation in the kidney.". Trabalho apresentado em 10th ITQB NOVA PhD Students Meeting, 2021.
  4. Correia, M João; Coelho, Nuno; Elsa Mecha; Sandra Silva; Bronze, Maria; Monteiro, EC; Pereira, Sofia A.. "Olive oil and arterial hypertension (htn): a focus on hydroxytyrosol". Trabalho apresentado em II Conference NOVASaude Nutrition, 2021.
  5. Sequeira CO; Caixas, Umbelina; Pereira, Sofia A.; Maravilha, C.; Casella, I.; Soto, K.; Branco, T.; et al. "Anti-Mullerian hormone a plausible indicator of cardiometabolic risk in HIV-infected women (PE10/6)". Trabalho apresentado em EACS 2019, 2019.
  6. Gonçalves-Dias, Clara; Soto, K; Sancho-Martinez, SM; Correia, M João; Coelho, Nuno; Prieto-Vicente, M; Monteiro, EC; López-Hernández, FJ; Pereira, Sofia A.. "Changes in mercapturates of cysteinedisulfides associate to acute kidney injury induced by cisplatin and gentamicin". Trabalho apresentado em ISN World Congress of Nephrology 2019, 2019.
  7. José Pedro Costa; Caixas, Umbelina; Sequeira CO; Morello, Judit; Sofia Azeredo-Lopes; Cláudia Á.F. Nunes; Teresa Branco; et al. "Urinary kynurenine-to-tryptophan ratio is not related to sex-hormones signature in HIV-infected woman at menopausal transition age". Trabalho apresentado em iMEDConference 11, 2019.
  8. Coelho, Nuno; Tomkiewicz, C; Correia, M João; Gonçalves-Dias, Clara; Barouki, R; Pereira, Sofia; Coumoul, X; Monteiro, EC. "Blockade of AhR reverts systemic hypertension induced by chronic intermittent hypoxia in rats". Trabalho apresentado em AhR Meeting. Paris, France, 2018.
  9. Gonçalves-Dias, Clara; Coelho, Nuno; Correia, M João; Lopes-Coelho, F; Meneses, MJ; Sousa-Lima, I; Serpa, Jacinta; et al. "Renal cysteine-disulfide stress is a common feature of cardiometabolic diseases.". Trabalho apresentado em I NoTeS Congress - Novel Therapeutic Strategies for Noncommunicable Diseases. Porto, Portugal, 2018.
  10. Sequeira CO; Gonçalves-Dias, Clara; Campos, P; Correia, M João; Coelho, NR; Soto, K; Monteiro, EC; Pereira, Sofia A.. "Mercapturates of cysteine-Sdisulfides in kidney dysfunction in HIV-infection.". Trabalho apresentado em 1st Workshop on Human Biomonitoring in Portugal, 2018.
  11. Gonçalves-Dias, Clara; Coelho, Nuno; Correia, M João; Grácio, PC; Diogo, Lucilia N; Monteiro, EC; Pereira, Sofia A.. "Mercapturates of cysteine-S-disulfides for risk assessment of exposure-related hypertension and kidney dysfunction". Trabalho apresentado em DiMoPEx Working Groups Meeting, 2nd International conference on Pollution in living and working environments and health. Bentivoglio, Italy, 2017.
  12. Coelho, Nuno; Gonçalves-Dias, Clara; Pereira, Sofia A.; Correia, M João; Pedro, AR; Monteiro, EC; Diogo, Lucília N.. "Cysteine oxidation in kidney: the effect of short and long-term exposure to chronic intermittent hypoxia.". Trabalho apresentado em EMBO Workshop: Thiol oxidation in toxicity and signaling. Sant Feliu de Guíxols, Spain, 2017.
  13. Gonçalves-Dias, Clara; Diogo, Lucília N.; Campos, P; Lemos, AR; Correia, M João; Morello, Judit; Batista, J; et al. "Mercapturate pathway and kidney disease progression in HIV-patients: a 1-year prospective study". Trabalho apresentado em ISN World Congress of Nephrology 2017. México, 2017.
  14. Gonçalves-Dias, Clara; Campos, P; Diogo, Lucília N.; Trigo, D; Correia, M João; Lemos, AR; Monteiro, EC; Soto, Karina; Pereira, Sofia A.. "Kidney disease progression in HIV-infected patients related with the detoxification of endogenous electrophilic species". Trabalho apresentado em 54th ERA-EDTA Congress, 2017.
  15. Gonçalves-Dias, Clara; Diogo, LN; Coelho, NR; Pedro, AR; Monteiro, EC; Soto, K; Pereira, Sofia A. "Mercapturates of cysteine-S-disulfides in kidney disease progression: a one-year prospective study in a HIV-infected population". Trabalho apresentado em EMBO Workshop: Thiol oxidation in toxicity and signaling, 2017.
  16. Sequeira, Catarina; Nádia Grilo; Shrika Harjivan; Umbelina Caixas; Lucília Diogo; Marques, M Matilde; Antunes, A M M; Monteiro, EC; Pereira, Sofia A.. "Monitoring of 8-hydroxy-efavirenz concentrations for management of mood changes". Trabalho apresentado em International Congress of Drug Therapy in HIV Infection, 2016.
    10.7448/IAS.19.8.21487
  17. Correia, M João; Gonçalves-Dias, Clara; Caixas, Umbelina; Grilo, Nádia M; Ana Lemos; Diva Trigo; Patrícia Pacheco; et al. "S-protein thiol-omics to assess the redox-modulation effects of antiretroviral drugs". Trabalho apresentado em International Congress of Drug Therapy in HIV Infection, Glasgow, 2016.
Recurso online
  1. Monteiro, EC. Layman summary: Zebrafish is an attractive model to anticipate drug-induced renal injury in humans. 2018. http://atlasofscience.org/zebrafish-is-an-attractive-model-to-anticipate-drug-induced-renal-injury-in-humans/.
Relatório
  1. 2022. Immunisation for old adults in Europe: scientific and social strategies. https://www.feam.eu/feam-publications/.
Resumo em conferência
  1. Monteiro, EC. "Metabolomics of drug-induced renal injury in zebrafishlarvae [oral presentation]". Trabalho apresentado em XLVII meeting of thePortugueseSociety of Pharmacology, 2018.
  2. Monteiro, EC. "Is zebrafish a good model to assess drug-inducedrenalinjury? [inivited oral presentation]". Trabalho apresentado em 3rd International Conference on Urine Omics and 2nd International CaparicaConference inTranslational Nephrology, 2017.
  3. Monteiro, EC. "Molecular targeting of proteins by homocysteine inhypercholesterolemia [oral presentation]". Trabalho apresentado em XLVI ReuniãoAnual da Sociedade Portuguesa de Farmacologia/ XXXIII Reunião deFarmacologia Clínica/ XV Reunião de Toxicologia, 2016.
  4. Monteiro, EC. "Modulation of paraoxonase-1 by nevirapine: comparisonbetween three in vitro models [oral presentation]". Trabalho apresentado em XLVIReunião Anual da Sociedade Portuguesa de Farmacologia/ XXXIII Reunião deFarmacologia Clínica/ XV Reunião de Toxicologia, 2016.
  5. Monteiro, EC. "Urinary N-acetylated cysteine-disulfides as indicators ofkidney disease progression in HIV-infected patients [oral presentation]". Trabalho apresentado em 7th European Congress of Pharmacology (EPHAR), 2016.
  6. Monteiro, EC. "Monitoring glomerular function in zebrafish larvae (Daniorerio) exposed to nephrotoxic drugs. [oral presentation]". Trabalho apresentado em XLV meeting of the Portuguese Society of Pharmacology, 2015.
  7. Monteiro, EC. "The role of Nevirapine phase I metabolites in the renalfunction of HIV-infected patients [oral presentation]". Trabalho apresentado em 1stInternational Caparica Conference in Translational Nephrology & 18thPortuguese Symposium on Renal Diseases, 2014.
  8. Monteiro, EC. "Antivíricos diretos e imunossupressores: interações [invitedoral presentation]". Trabalho apresentado em Workshop Hepatite C - InovaçãoFarmacologia e Transplantação, 2014.
  9. Monteiro, EC. "Relevance of CYP2C19 genotypes in Nevirapinebiotransformation [oral presentation]". Trabalho apresentado em European Society ofPharmacogenomics and Theranostics (ESPT) Second Conference.Pharmacogenomics: from Cell to Clinic, 2013.
  10. Monteiro, EC. "Effect of chronic exposure to the antiretroviral drugnevirapine on paraoxonase-1 activities in HIV-infected patients [oralpresentation]". Trabalho apresentado em 2nd International Conference onOccupational & Environmental Toxicology, 2013.
  11. Monteiro, EC. "Biomedical models for translational research [invited oralpresentation]". Trabalho apresentado em 3º Congresso Internacional de Enfermagem Veterinária, 2013.
  12. Monteiro, EC. "Hemoglobin adducts from the antiretroviralabacavir in HIV-infected patients as evidence of bioactivation [oralpresentation]". Trabalho apresentado em 244th ACS National Meeting & Exposition, Philadelphia, 2012.

Propriedade Intelectual

Patente
  1. Monteiro, EC. 2019. "2-hydroxy-nevirapine analogues or derivatives for use in the treatment of diseases related to high density lipoprotein dysfunction. PPI 2019/20066".

Outros

Outra produção
  1. Aryl hydrocarbon receptor antagonists - a new entry in antihypertensive armamentarium of obstructive sleep apnea?. 2021. Pereira SA; Nuno R. Coelho; Celine Tomkiewcz; Maria Joao Correia; Antonio B. Pimpao; Robert Barouki; Xavier Coumoul; et al. https://novaresearch.unl.pt/en/publications/53cdf1c1-8bfa-4732-8d69-e835b48bc6ce.
  2. Investigator initiated clinical trials (IICTs): a systematic search in registries comparing Czech Republic and Portugal in terms of funding policies and scientific outcomes. 2020. Catarina Madeira; Lenka Horavová; Francisco dos Santos; Joana Batuca; Katerina Nebeska; Lenka Souckova; Christine Kubiak; et al. https://doi.org/10.21203/rs.2.24789/v1.
    10.21203/rs.2.24789/v1
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2021/04/29 Phenotyping SULT in Man: a Simple Metric Using Paracetamol as Probe (R3064 poster) ASPET Annual Meeting at EB 2021

Orientação

Título / Tema
Papel desempenhado 		Curso (Tipo)
Instituição / Organização
2016 - 2020 ARYL HYDROCARBON RECEPTOR (AHR): A THERAPEUTIC TARGET FOR SYSTEMIC HYPERTENSION ASSOCIATED WITH CHRONIC INTERMITTENT HYPOXIA
Orientador
 Doutor em Mecanismos de Doença e Medicina Regenerativa (Doutoramento)
Universidade Nova de Lisboa, Portugal
2014 - 2019 The multimorbidity of asthma and rhinitis: from epidemiologic data to molecular traits
Coorientador
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2014 - 2018 Teaching an old drug new tricks: reprofiling of nevirapine as an HDL modulator
Coorientador
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2010 - 2015 Evaluation of antihypertensive drugs in patients with obstructive sleep apnea and in rat s submitted to chronic intermittent hypoxia
Coorientador
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2010 - 2014 New insights for understanding postoperative cognitive dysfunction
Coorientador
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2009 - 2013 O2/CO2sensitive cAMP signaling pathway in peripher al chemoreceptors
Coorientador
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2005 - 2011 Functional evaluation of carotid body in ageing
Orientador
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2006 - 2010 Therapeutic drug monitoring of efavirenz in clinical practice and long term effects of the drug
Orientador
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2003 - 2007 Functional significance of adenosine receptors in carotid body chemosensory activity in control and chronically hypoxic animals
Orientador
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação) 		Instituição / Organização
2024 - 2024 Organization of the Meeting of the Portuguese Society of Pharmacology 2024 (2024/02/07 - 2024/02/09)
Conferência (Presidente da Comissão Organizadora)
2022/06/27 - 2022/06/30 Organization of the Meeting of the International Society for Arterial Chemoreception (2022/06/27 - 2022/06/30)
Encontro
 Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2014 - 2015 Organization of the Meeting of the Portguese Society of Pharmacology 2015 (2015 - 2015)
Encontro
 Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal

Participação em evento

Descrição da atividade
Tipo de evento 		Nome do evento
Instituição / Organização
2021/11/09 - Atual Roundtable ´´Training of Clinical Research Centers in Portugal``: How to promote quality, efficiency and cooperation?
Mesa-redonda
 Prémios AICIB 2021
2010 - Atual Pariticipation in the OPEN DAYS of the institute (outreach activities).
Outro
 OPEN DAYS CEDOC | FCM
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2022/01/31 - 2022/01/31 How should Europe prepare and respond to cross-border health threats: HERA?
Oficina (workshop)
 How should Europe prepare and respond to cross-border health threats: HERA?
Federation of European Academies of Medicine, FEAM, Bélgica
2021/02/18 - 2021/02/18 Chair at CLINICAL PHARMACOLOGY II session
Encontro
 SPF Meeting 2021
Universidade de Lisboa Faculdade de Farmácia, Portugal

Sociedade Portuguesa de Farmacologia, Portugal
2021/02/17 - 2021/02/17 ROUNDTABLE member: Teaching Pharmacology, Therapeutics and Toxicology
Encontro
 SPF Meeting 2021
Universidade de Lisboa Faculdade de Farmácia, Portugal

Sociedade Portuguesa de Farmacologia, Portugal

Júri de grau académico

Tema
Tipo de participação 		Nome do candidato (Tipo de grau)
Instituição / Organização
2021/12/20 "Targeting the carotid bodies to treat obesity"
Presidente do júri
 Bernardete Sofia Freitas de Melo (Doutoramento)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal

Comissão de avaliação

Descrição da atividade
Tipo de assessoria 		Instituição / Organização Entidade financiadora
2018 - 2018 Member of the evaluation panel of the research grants supported by the "Agence Nationale de Sécurité du Medicament et des Produits de Santé"
Membro
 Agence nationale de sécurité du médicament et des produits de santé, França
2010 - 2017 Evaluator of research grants and scientific projects at Foundation for Science and Technology, Portuguese Ministry of Education and Science
Avaliador
 Fundação para a Ciência e a Tecnologia, Portugal

Consultoria / Parecer

Descrição da atividade Instituição / Organização
2018 - Atual iNOVA4Health Management Board Universidade Nova de Lisboa, Portugal

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2022 - Atual Chair of the curricular unit Pharmacology 2 in the Integrated Master of Medicina (Mestrado integrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019 - Atual Curricular Unit Core Methodologies in Research. Ciências da Saúde (Doutoramento) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019 - Atual Chair of the Curricular Unit Core Methodologies in Biomedical and Clinical Research, PhD Program in Health Sciences (Doutoramento) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019 - Atual Chair of the Curricular Unit Pathophysiology and Therapeutic Targets, Integrated Master in Medicine (Mestrado integrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2012 - Atual Nuclear Curricular Unit of Phatophysiology and Therapeutic Targets Medicina (Mestrado integrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2022 - 2022 Module 6 - Exploratory Development (Molecule for Proof of Concept) (Pós-Graduação) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2022 - 2022 Module 4 - Non-Clinical Tests (Pós-Graduação) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2017 - 2020 Chair of the Curricular Unit Medical Devices, Integrated Master in Medicine Medicina (Mestrado integrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2013 - 2018 Chair of the Curricular Units Pharmacology and/or General Pharmacology, Integrated Master of Medicine Medicina (Mestrado integrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2003 - 2018 Curricular units Pharmacology and/or General Pharmacology Medicina (Mestrado integrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal

Membro de associação

Nome da associação Tipo de participação
2021 - Atual CoLAB trials, Nova Medical School Representative
2019 - Atual Full member of the Portuguese Academy of Medicine
2017 - 2020 President of the International Society for Arterial Chemoreception (ISAC) Presdent
2016 - 2018 Correspondent member of the Portuguese Academy of Medicine Correspondent Member
2009 - 2017 Society of Medical Sciences of Lisbon Member of the Direction
2009 - 2013 President of the Portuguese Society of Pharmacology and Clinical Pharmacology President

Membro de comissão

Descrição da atividade
Tipo de participação 		Instituição / Organização
2021 - Atual Council Member, Portuguese Academy of Medicine representative
Membro
 Federation of European Academies of Medicine, FEAM, Bélgica
2020 - Atual Member of the executive board of CEDOC (CENTRO DE ESTUDOS DE DOENÇAS CRÓNICAS)
Membro
 Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2018 - Atual External advisor of the Scientific Committee of the Spanish Clinical Research Network ISCIII
Consultor
 Instituto de Salud Carlos III, Espanha
2014 - Atual Member of the Network Committee
Membro
 European Clinical Research Infrastructure Network, França
2013 - Atual Member of the scientific council of the “Agence Nationale de Sécurité du Medicament et des Produits de Santé”
Membro
 Agence nationale de sécurité du médicament et des produits de santé, França
2013 - Atual Member of the Scientific Council
Membro
 Agence nationale de sécurité du médicament et des produits de santé, França
2013 - Atual Senior Clinical and Scientific lead of the academic clinical trial unit NOVACRU
Outro
 Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2009 - Atual Member of the National Ethics Committee for Clinical Research (CEIC). Evaluator of Clinical trials
Membro
 Comissão de Ética para a Investigação Clínica, Portugal
2009 - Atual Member
Membro
 CEIC, Comissão de Ética para a Investigação Clínica, Portugal
2017 - 2020 Vice-chair of the ECRIN-ERIC steering committee (European Clinical Research Infrastructure Network/ European Research Infrastructures Consortium)
2013 - 2018 Member of the pedagogic council of the Nova Medical School Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2017 - 2017 Preparation of the Portuguese Strategic Agenda for Research and Innovation in Health.
Membro
2013 - 2014 Delegate of Portugal in the FP 7 and Horizon 2020- topic, SC1 "Health, demographic change and wellbeing"
2010 - 2011 Collaborator in the preparation of Portuguese National Health Programme 2011-2016 in the area of drugs, technologies and medical devices